Relative survival of patients with supratentorial low-grade gliomas
We sought to assess the population-based estimates of age-standardized survival among patients with low-grade gliomas (LGG) and to determine the impact of age and time on relative survival (RS). Data from the Surveillance, Epidemiology, and End Results (SEER) program of NCI from 1973 through 2006 we...
Saved in:
Published in | Neuro-oncology (Charlottesville, Va.) Vol. 14; no. 8; pp. 1062 - 1069 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.08.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We sought to assess the population-based estimates of age-standardized survival among patients with low-grade gliomas (LGG) and to determine the impact of age and time on relative survival (RS). Data from the Surveillance, Epidemiology, and End Results (SEER) program of NCI from 1973 through 2006 were analyzed to assess survival among 5037 patients. Relationships were modeled using Dickman's piecewise constant hazards RS model. The 3- and 10-year age-standardized RS were 67% and 37%, respectively. When analyzed by age group, the 10-year overall survival (OS) and RS for children (age, <16 years), young adults (age, 16-39 years), adults (age, 40-64 years), and older patients (age, ≥65 years) were 86% and 86%, 61% and 62%, 40% and 43%, and 10% and 14%, respectively. The observed difference between OS and RS was larger among older patients (4%) and smallest among children (<1%). Older patients were 30.5 times (excess hazard ratio [eHR]; 95% confidence interval [CI], 20.3-50.0) as likely as young adults to die during the first year and 18.2 times as likely to die during the second year. Adults were 5.3 (eHR; 95% CI, 3.5-8.1) times as likely to die during their first year as young adults. In the remaining years, the observed survival differences were substantially decreased, and the presence of an age-by-follow-up interaction was observed. Survival among older patients with LGG was substantially different from the one computed for young adults and children. Despite the hazards across age groups not being proportional, RS does not provide additional information, compared with OS, in patients with LGG. |
---|---|
AbstractList | We sought to assess the population-based estimates of age-standardized survival among patients with low-grade gliomas (LGG) and to determine the impact of age and time on relative survival (RS). Data from the Surveillance, Epidemiology, and End Results (SEER) program of NCI from 1973 through 2006 were analyzed to assess survival among 5037 patients. Relationships were modeled using Dickman's piecewise constant hazards RS model. The 3- and 10-year age-standardized RS were 67% and 37%, respectively. When analyzed by age group, the 10-year overall survival (OS) and RS for children (age, <16 years), young adults (age, 16-39 years), adults (age, 40-64 years), and older patients (age, greater than or equal to 65 years) were 86% and 86%, 61% and 62%, 40% and 43%, and 10% and 14%, respectively. The observed difference between OS and RS was larger among older patients (4%) and smallest among children (<1%). Older patients were 30.5 times (excess hazard ratio [eHR]; 95% confidence interval [CI], 20.3-50.0) as likely as young adults to die during the first year and 18.2 times as likely to die during the second year. Adults were 5.3 (eHR; 95% CI, 3.5-8.1) times as likely to die during their first year as young adults. In the remaining years, the observed survival differences were substantially decreased, and the presence of an age-by-follow-up interaction was observed. Survival among older patients with LGG was substantially different from the one computed for young adults and children. Despite the hazards across age groups not being proportional, RS does not provide additional information, compared with OS, in patients with LGG. We sought to assess the population-based estimates of age-standardized survival among patients with low-grade gliomas (LGG) and to determine the impact of age and time on relative survival (RS). Data from the Surveillance, Epidemiology, and End Results (SEER) program of NCI from 1973 through 2006 were analyzed to assess survival among 5037 patients. Relationships were modeled using Dickman's piecewise constant hazards RS model. The 3- and 10-year age-standardized RS were 67% and 37%, respectively. When analyzed by age group, the 10-year overall survival (OS) and RS for children (age, <16 years), young adults (age, 16-39 years), adults (age, 40-64 years), and older patients (age, ≥65 years) were 86% and 86%, 61% and 62%, 40% and 43%, and 10% and 14%, respectively. The observed difference between OS and RS was larger among older patients (4%) and smallest among children (<1%). Older patients were 30.5 times (excess hazard ratio [eHR]; 95% confidence interval [CI], 20.3-50.0) as likely as young adults to die during the first year and 18.2 times as likely to die during the second year. Adults were 5.3 (eHR; 95% CI, 3.5-8.1) times as likely to die during their first year as young adults. In the remaining years, the observed survival differences were substantially decreased, and the presence of an age-by-follow-up interaction was observed. Survival among older patients with LGG was substantially different from the one computed for young adults and children. Despite the hazards across age groups not being proportional, RS does not provide additional information, compared with OS, in patients with LGG. |
Author | Gautschi, Oliver P Schaller, Karl Weber, Damien C Schatlo, Bawarjan Smoll, Nicolas R |
AuthorAffiliation | Department of Clinical Neurosciences, Department of Neurosurgery, Geneva University Hospital, Geneva , Switzerland (N.R.S., O.P.G., B.S., K.S.); Gippsland Medical School , Monash University , Churchill, Victoria , Australia (N.R.S.); Department of Radiation Oncology , Geneva University Hospital , Geneva , Switzerland (D.C.W.) |
AuthorAffiliation_xml | – name: Department of Clinical Neurosciences, Department of Neurosurgery, Geneva University Hospital, Geneva , Switzerland (N.R.S., O.P.G., B.S., K.S.); Gippsland Medical School , Monash University , Churchill, Victoria , Australia (N.R.S.); Department of Radiation Oncology , Geneva University Hospital , Geneva , Switzerland (D.C.W.) |
Author_xml | – sequence: 1 givenname: Nicolas R surname: Smoll fullname: Smoll, Nicolas R email: nrsmoll@me.com organization: Department of Clinical Neurosciences, Department of Neurosurgery, Geneva University Hospital, Geneva, Switzerland. nrsmoll@me.com – sequence: 2 givenname: Oliver P surname: Gautschi fullname: Gautschi, Oliver P – sequence: 3 givenname: Bawarjan surname: Schatlo fullname: Schatlo, Bawarjan – sequence: 4 givenname: Karl surname: Schaller fullname: Schaller, Karl – sequence: 5 givenname: Damien C surname: Weber fullname: Weber, Damien C |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22773277$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtLAzEUhYNU7EOXbmWWbsbmOZnZCFJ8QUEQXYdM5k4bmU5qMtPivzfaWnTlIiQ35-NwLmeMBq1rAaFzgq8ILti0hd61Ztq6QDg_QiMiKEtFnmWD7zdNc0HkEI1DeMOYEpGREzSkVEoWzwjNnqHRnd1AEnq_sRvdJK5O1vEL2i4kW9sto7L2uouz8zbqjdumC68rSBaNdSsdTtFxrZsAZ_t7gl7vbl9mD-n86f5xdjNPDae4S03NDSm01sA4lYUoZIUJFCSXHFMhGRDgpTClpiUuCp5pzKEujJY0pxLnFZug653vui9XUJmYyOtGrb1daf-hnLbqr9LapVq4jWIc5zTLosHl3sC79x5Cp1Y2GGga3YLrgyJCkIxnlNL_UcxwLiljJKLpDjXeheChPiQiWH11pHYdqV1Hkb_4vcaB_imFfQJX8ZIr |
CitedBy_id | crossref_primary_10_3389_fgene_2022_1036460 crossref_primary_10_3389_fimmu_2021_731048 crossref_primary_10_2147_OTT_S258631 crossref_primary_10_1002_cncr_28032 crossref_primary_10_1055_s_0042_1742333 crossref_primary_10_3389_fneur_2020_610163 crossref_primary_10_1016_j_compbiomed_2016_12_017 crossref_primary_10_2217_cns_14_7 crossref_primary_10_3389_fcell_2020_594112 crossref_primary_10_1155_2020_7035847 crossref_primary_10_3390_radiation1030019 crossref_primary_10_3892_ol_2015_3183 crossref_primary_10_1080_14737175_2018_1425617 crossref_primary_10_1007_s11060_015_1952_5 crossref_primary_10_1093_neuonc_nou053 crossref_primary_10_3390_nu12010196 crossref_primary_10_1111_ane_12973 crossref_primary_10_1155_2022_1734847 crossref_primary_10_1016_j_clon_2013_04_005 crossref_primary_10_1093_neuonc_noy095 crossref_primary_10_3892_etm_2015_2906 crossref_primary_10_1016_j_isci_2022_104918 crossref_primary_10_3892_etm_2023_11952 crossref_primary_10_7314_APJCP_2014_15_16_6973 crossref_primary_10_1038_s41392_021_00855_2 crossref_primary_10_1007_s11060_013_1103_9 crossref_primary_10_1186_s12883_022_02879_9 crossref_primary_10_1002_cncr_29237 crossref_primary_10_3389_fmolb_2021_706949 crossref_primary_10_1515_revneuro_2016_0066 crossref_primary_10_3390_genes14030701 crossref_primary_10_1007_s11060_014_1563_6 crossref_primary_10_3389_fgene_2022_1026192 crossref_primary_10_3892_mmr_2015_4129 crossref_primary_10_1016_j_radonc_2019_04_027 crossref_primary_10_1042_BSR20170100 crossref_primary_10_3389_fcell_2023_1295891 crossref_primary_10_1002_adbi_202300439 crossref_primary_10_1016_j_suronc_2016_09_003 |
Cites_doi | 10.1200/JCO.2002.08.121 10.1200/JCO.2009.25.7121 10.1215/15228517-2006-036 10.1038/sj.bjc.6603390 10.1002/mpo.2950250603 10.1002/1097-0142(19851001)56:7+<1818::AID-CNCR2820561320>3.0.CO;2-9 10.1056/NEJM199403313301303 10.1002/sim.1597 10.1016/S0360-3016(96)00352-5 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-# 10.1002/jso.20036 10.1017/S0317167100008313 10.1016/j.ejca.2011.03.011 10.1002/cncr.26387 10.1007/s00401-005-0991-y 10.1016/S0140-6736(05)67070-5 10.1002/cncr.21733 10.1200/JCO.2006.06.8213 10.1212/WNL.0b013e3181c6781e 10.1016/S0360-3016(01)02692-X 10.3171/jns.1996.84.5.0721 10.1212/01.wnl.0000218270.12495.9a 10.1200/JCO.2006.05.9238 |
ContentType | Journal Article |
Copyright | The Author(s) 2012. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2012 |
Copyright_xml | – notice: The Author(s) 2012. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2012 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7TK 5PM |
DOI | 10.1093/neuonc/nos144 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Neurosciences Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitleList | Neurosciences Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1523-5866 |
EndPage | 1069 |
ExternalDocumentID | 10_1093_neuonc_nos144 22773277 |
Genre | Journal Article |
GroupedDBID | --- .2P .I3 .XZ .ZR 0R~ 123 18M 1TH 29N 2WC 36B 4.4 48X 53G 5VS 5WD 70D AABZA AACZT AAJKP AAJQQ AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP ABEUO ABIXL ABJNI ABKDP ABNHQ ABNKS ABPTD ABQLI ABQNK ABWST ABXVV ABZBJ ACGFO ACGFS ACUFI ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHXPO AIAGR AIJHB AJEEA AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC AOIJS APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CGR CS3 CUY CVF CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBS ECM EE~ EIF EJD EMB EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HYE HZ~ IOX J21 KBUDW KOP KQ8 KSI KSN M49 MHKGH N9A NGC NOMLY NOYVH NPM NU- O0~ O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P P6G PAFKI PEELM Q1. Q5Y RD5 RHF ROX RPM RUSNO RW1 RXO SV3 TEORI TJX TR2 UDS W8F WOQ X7H YAYTL YKOAZ YXANX ~91 AASNB AAYXX CITATION 7X8 7TK 5PM |
ID | FETCH-LOGICAL-c420t-cf4c19aaae34279597d01e9187402573e1e4b5cba2b09946a04ef9ca7282708d3 |
IEDL.DBID | RPM |
ISSN | 1522-8517 |
IngestDate | Tue Sep 17 21:15:56 EDT 2024 Fri Oct 25 23:18:37 EDT 2024 Fri Oct 25 10:56:38 EDT 2024 Fri Aug 23 02:51:29 EDT 2024 Wed Oct 16 00:52:16 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c420t-cf4c19aaae34279597d01e9187402573e1e4b5cba2b09946a04ef9ca7282708d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://academic.oup.com/neuro-oncology/article-pdf/14/8/1062/4030719/nos144.pdf |
PMID | 22773277 |
PQID | 1030872331 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3408266 proquest_miscellaneous_1551646222 proquest_miscellaneous_1030872331 crossref_primary_10_1093_neuonc_nos144 pubmed_primary_22773277 |
PublicationCentury | 2000 |
PublicationDate | 2012-08-01 |
PublicationDateYYYYMMDD | 2012-08-01 |
PublicationDate_xml | – month: 08 year: 2012 text: 2012-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Neuro-oncology (Charlottesville, Va.) |
PublicationTitleAlternate | Neuro Oncol |
PublicationYear | 2012 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | (23_36447516) 2007; 9 Sutton (26_16206015) 1996; 84 (10_33609952) 1996; 78 van den Bent (4_19462302) 2005; 366 (17_43006990) 2007; 25 Felix (18_16049054) 1995; 25 Torres (27_14683914) 1994; 330 (16_41205203) 2010; 331 (24_43006992) 2002; 20 Walker (20_22983433) 2006; 95 (29_43006993) 1985; 56 (3_43006989) 2006; 45 Hakulinen (13_39886506) 2011; 47 Varela (22_18109566) 2004; 86 Karim (7_16541385) 1996; 36 Ohgaki (2_18680128) 2005; 109 Walker (19_22163591) 2006; 66 (5_33736729) 2006; 106 Karim (6_16938800) 2002; 52 Dickman (12_17973185) 2004; 23 (14_35969828) 2009; 73 Vassilyadi (28_36135661) 2009; 36 (21_43006991) 2006; 24 (15_37303171) 2010; 28 Smoll (25_40564859) 2012; 118 |
References_xml | – volume: 20 start-page: 2076 year: 2002 ident: 24_43006992 publication-title: JOURNAL OF CLINICAL ONCOLOGY OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY doi: 10.1200/JCO.2002.08.121 – volume: 28 start-page: 3054 issn: 0732-183X issue: 18 year: 2010 ident: 15_37303171 publication-title: Journal of Clinical Oncology doi: 10.1200/JCO.2009.25.7121 – volume: 331 start-page: 435 issn: 0036-8075 year: 2010 ident: 16_41205203 publication-title: Science – volume: 9 start-page: 113 issn: 1522-8517 issue: 2 year: 2007 ident: 23_36447516 publication-title: Neuro-Oncology doi: 10.1215/15228517-2006-036 – volume: 95 start-page: 1424 issn: 1532-1827 issue: 10 year: 2006 ident: 20_22983433 publication-title: British Journal of Cancer doi: 10.1038/sj.bjc.6603390 contributor: fullname: Walker – volume: 45 start-page: 272 issn: 0001-6381 year: 2006 ident: 3_43006989 publication-title: Acta oncol gica – volume: 25 start-page: 431 issn: 0098-1532 issue: 6 year: 1995 ident: 18_16049054 publication-title: Medical and pediatric oncology doi: 10.1002/mpo.2950250603 contributor: fullname: Felix – volume: 56 start-page: 1818 issn: 1097-0142 year: 1985 ident: 29_43006993 doi: 10.1002/1097-0142(19851001)56:7+<1818::AID-CNCR2820561320>3.0.CO;2-9 – volume: 330 start-page: 892 issn: 0028-4793 issue: 13 year: 1994 ident: 27_14683914 publication-title: New England Journal of Medicine doi: 10.1056/NEJM199403313301303 contributor: fullname: Torres – volume: 23 start-page: 51 issn: 0277-6715 issue: 1 year: 2004 ident: 12_17973185 publication-title: Statistics in medicine doi: 10.1002/sim.1597 contributor: fullname: Dickman – volume: 36 start-page: 549 issn: 0360-3016 issue: 3 year: 1996 ident: 7_16541385 publication-title: International journal of radiation oncology, biology, physics doi: 10.1016/S0360-3016(96)00352-5 contributor: fullname: Karim – volume: 78 start-page: 2004 issn: 1097-0142 year: 1996 ident: 10_33609952 doi: 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-# – volume: 86 start-page: 34 issn: 0022-4790 issue: 1 year: 2004 ident: 22_18109566 publication-title: Journal of surgical oncology doi: 10.1002/jso.20036 contributor: fullname: Varela – volume: 36 start-page: 707 issn: 0317-1671 issue: 6 year: 2009 ident: 28_36135661 publication-title: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques doi: 10.1017/S0317167100008313 contributor: fullname: Vassilyadi – volume: 47 start-page: 2202 issn: 0959-8049 issue: 14 year: 2011 ident: 13_39886506 publication-title: European journal of cancer (Oxford, England : 1990) doi: 10.1016/j.ejca.2011.03.011 contributor: fullname: Hakulinen – volume: 118 start-page: 1313 issn: 1097-0142 issue: 5 year: 2012 ident: 25_40564859 doi: 10.1002/cncr.26387 contributor: fullname: Smoll – volume: 109 start-page: 93 issn: 0001-6322 issue: 1 year: 2005 ident: 2_18680128 publication-title: Acta neuropathologica doi: 10.1007/s00401-005-0991-y contributor: fullname: Ohgaki – volume: 366 start-page: 985 issn: 0140-6736 issue: 9490 year: 2005 ident: 4_19462302 publication-title: Lancet doi: 10.1016/S0140-6736(05)67070-5 contributor: fullname: van den Bent – volume: 106 start-page: 1358 issn: 1097-0142 year: 2006 ident: 5_33736729 doi: 10.1002/cncr.21733 – volume: 25 start-page: 682 year: 2007 ident: 17_43006990 publication-title: JOURNAL OF CLINICAL ONCOLOGY OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY doi: 10.1200/JCO.2006.06.8213 – volume: 73 start-page: 2093 issn: 0028-3878 issue: 24 year: 2009 ident: 14_35969828 publication-title: Neurology doi: 10.1212/WNL.0b013e3181c6781e – volume: 52 start-page: 316 issn: 0360-3016 issue: 2 year: 2002 ident: 6_16938800 publication-title: International journal of radiation oncology, biology, physics doi: 10.1016/S0360-3016(01)02692-X contributor: fullname: Karim – volume: 84 start-page: 721 issn: 0022-3085 issue: 5 year: 1996 ident: 26_16206015 publication-title: Journal of neurosurgery doi: 10.3171/jns.1996.84.5.0721 contributor: fullname: Sutton – volume: 66 start-page: 1661 issn: 0028-3878 issue: 11 year: 2006 ident: 19_22163591 publication-title: Neurology doi: 10.1212/01.wnl.0000218270.12495.9a contributor: fullname: Walker – volume: 24 start-page: 4758 year: 2006 ident: 21_43006991 publication-title: JOURNAL OF CLINICAL ONCOLOGY OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY doi: 10.1200/JCO.2006.05.9238 |
SSID | ssj0021561 |
Score | 2.2647285 |
Snippet | We sought to assess the population-based estimates of age-standardized survival among patients with low-grade gliomas (LGG) and to determine the impact of age... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 1062 |
SubjectTerms | Adolescent Adult Age Distribution Aged Child Clinical Investigations Female Glioma - mortality Glioma - pathology Humans Kaplan-Meier Estimate Male Middle Aged Neoplasm Grading SEER Program Supratentorial Neoplasms - mortality Supratentorial Neoplasms - pathology Young Adult |
Title | Relative survival of patients with supratentorial low-grade gliomas |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22773277 https://search.proquest.com/docview/1030872331 https://search.proquest.com/docview/1551646222 https://pubmed.ncbi.nlm.nih.gov/PMC3408266 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED61HRAL4k15VEFCbGkedp1mRBWlQipioFK3yHacUql1qj7g73OOk4qCxMCQyY4Sne_i-3KfvwO469BMkJRipBlyGGXSd2P8FLsKEVDKMqnSgjw-fGGDEX0ed8Y16FRnYQrSvhTTtp7N23r6XnArF3PpVTwx73XYI6ZLMmNeHerooBVEL1EWAhIrkoooyzSeL4U1Ebl7Wm1yLT2drxBGGBngMIoIXrt70q9E8ydf8tsG1D-EgzJzdB7sGx5BTelj2BuWtfET6Fle24dyVhuMf_QgJ8-cUjd15ZgfrjiyMNIQ2iiD4Pgs_3QnS54qZzKbGqLQKYz6j2-9gVu2SHAlDf21KzMqg5hzrggNTdvwKPUDFReN9jAYiQoUFR0peCgwFaSM-1RlseQRIq3I76bkDBo61-oCHJGSriQki5lIqZSKUzRlUe5F8E0Ea8J9ZaRkYZUwElvBJok1bGIN24TbyoQJ-qopQHCt8s0qCQr9wZCQ4I85pnJHGaYtTTi3Zt8-rlqvJkQ7C7KdYLSyd0fQhQrN7NJlLv995xXsY64UWu7fNTTWy426wXxkLVpQfxoHrcILvwDJ6ePf |
link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED5BkYAF8aY8g4TYQh52HTKiClSgRQwgsUW245RKrVO1Dfx9znFSUZAYGDLZUaLznX1f7st3ABctmgmSUow0Qw6jTPpujFuxqxABpSyTKi3J470n1nmlD2-ttyVo1f_ClKR9KQZXeji60oP3kls5Hkmv5ol5z702MV2SGfOWYQXj1ac1SK9wFkISK5OKOMu0nq-kNRG7e1oVuZaezqcIJIwQcBhFBK_FU-lXqvmTMfntCLrbhI0qd3Ru7DtuwZLS27Daq6rjO9C2zLYP5UwL3AHQh5w8cyrl1KljPrniyNiIQ2ijDYLjw_zT7U94qpz-cGCoQrvwenf70u64VZMEV9LQn7kyozKIOeeK0NA0Do9SP1Bx2WoPw5GoQFHRkoKHApNByrhPVRZLHiHWivzrlOxBQ-daHYAjUnItCcliJlIqpeIUTVkWfBF-E8GacFkbKRlbLYzE1rBJYg2bWMM24bw2YYLeakoQXKu8mCZBqUAYEhL8McfU7ijDxKUJ-9bs88fV69WEaGFB5hOMWvbiCDpRqZpdOc3hv-88g7XOS6-bdO-fHo9gHTOn0DIBj6ExmxTqBLOTmTgtffELj37mRA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xSBUXxE5Zg4S4pVnsOuSIChVbEQcq9RZ5C1QqTkVb-H3GcYIoSBw45GRbicYz9rzM0xuA0zbNBVEUI82SwyiToZ_iUexrRECK5VKrkjzee2DXfXo7aA--tfoqSftSDFtm9Noyw5eSWzl-lUHNEwseex1iuyQzFoxVHizCMsZsyGqgXmEthCVOKhWxlm0_X8lrIn4PjJ4VRgammCCYsGLAcZIQfOZvpl_p5k_W5LdrqLsGq1X-6F2471yHBW02oNGrKuSb0HHstnftTWZ4CqAfeUXuVeqpE8_-dsWRsRWIMFYfBMdHxYf__MaV9p5HQ0sX2oJ-9-qpc-1XjRJ8SeNw6sucyijlnGtCY9s8PFFhpNOy3R6GJNGRpqItBY8FJoSU8ZDqPJU8QbyVhOeKbMOSKYzeBU8oci4JyVMmFJVSc4qmLIu-CMGJYE04q42UjZ0eRubq2CRzhs2cYZtwUpswQ4-1ZQhudDGbZFGpQhgTEv0xx9bvKMPkpQk7zuxfr6v3qwnJ3IZ8TbCK2fMj6EilcnblOHv_XnkMjcfLbnZ_83C3DyuYPMWODHgAS9O3mT7EBGUqjkpX_ATdpedX |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relative+survival+of+patients+with+supratentorial+low-grade+gliomas&rft.jtitle=Neuro-oncology+%28Charlottesville%2C+Va.%29&rft.au=Smoll%2C+Nicolas+R&rft.au=Gautschi%2C+Oliver+P&rft.au=Schatlo%2C+Bawarjan&rft.au=Schaller%2C+Karl&rft.date=2012-08-01&rft.eissn=1523-5866&rft.volume=14&rft.issue=8&rft.spage=1062&rft_id=info:doi/10.1093%2Fneuonc%2Fnos144&rft_id=info%3Apmid%2F22773277&rft.externalDocID=22773277 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1522-8517&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1522-8517&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1522-8517&client=summon |